Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2010
August 2, 2010
- Study Published in the Journal Endocrinology Further Confirms Therapeutic Potential of PROLOR's Long-Acting Human Growth Hormone
- British Researchers Report that TB4 is Essential to Heart Development
- Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients
- BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal Clinical Cancer Research
- New studies question vascular multiple sclerosis hypothesis and treatment
- How blocking the 'Programmed Death 1' protein may treat or prevent sepsis and severe infection
August 3, 2010
- Long-Term Follow-Up of DCVax-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival
- Encouraging Preliminary Safety and Efficacy Trends in Phase 2 Clinical Study of PEG-PAL in PKU
- Ketamine May Relieve Depression Quickly for Those With Treatment-Resistant Bipolar Disorder
- Chili peppers come with blood pressure benefits
- Disrupted circadian rhythm may cause triglycerides to rise
- Memantine in Alzheimer?s disease: reliable analyses are required
- Revascularization in elderly seniors may help survival rates after heart attack
August 4, 2010
- Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
- In Pivotal Phase III Studies, Merck's Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies
August 5, 2010
- Vicept Therapeutics Announces Positive Clinical Study Results of V-101 for the Treatment of the Erythema of Rosacea
- TEMPO Extension Study Further Demonstrates the Benefits of Azilect in Early Parkinson's Disease Patients
August 6, 2010
- ViroPharma Announces Publication of Cinryze (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
- Published Study Demonstrated Once-Daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII Provided Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
- YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
- Large Risk Schizophrenia Marker Revealed
- Clinical Phase I Results of Ganymed's iMAB362 Antibody Demonstrate Excellent Safety
- BioMarin Announces Results for Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy
- Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation
August 9, 2010
- Data Demonstrate Zyclara (Imiquimod) Cream, 3.75% Greatly Improves Efficacy of Cryosurgery in Reducing Actinic Keratoses (AK)
- Rotavirus Vaccine Trials Successful In Asia And Africa; Vaccine Should Now Be Rolled Out Across Both Continents
- Curis Provides Update on Genentech's Phase II Clinical Trial of GDC-0449 in Advanced Ovarian Cancer Patients
- Pluristem's PLX Cells Found to Be Effective in Treating Neuropathic and Inflammatory Pain
- Acucela Announces Experimental Eye Research Publication; Paper Outlines First Demonstrated Effect of Visual Cycle Modulation Treatment on Retinopathy
- Stelara Three-Year Efficacy and Safety Data Presented on Patients with Moderate to Severe Plaque Psoriasis
- Alnylam Scientists and Collaborators Report Significant New Advances in RNAi Delivery
- New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
- Fibrocell Science, Inc. Submits Clinical Study Report (CSR) to U.S. Food & Drug Administration for Phase II/III Trial of Azficel-T in Acne Scarring
- Published Study Demonstrated Once-Daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII Provided Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
- QRxPharma Announces Positive Phase 2 Proof-of-Concept Data for MoxDuo IV Pain Therapy
August 10, 2010
- Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
- Elan And Transition Therapeutics Announce Topline Summary Results Of Phase 2 Study and Plans for Phase 3 for ELND005 (Scyllo-inositol )
- A Breakthrough in Cancer Therapy Through RNL BIO's Adult Stem Cell Technology
- GSK and Genmab Announce Topline Results from the Concluded Pivotal Trial of Arzerra (Ofatumumab) in Fludarabine and Alemtuzumab Refractory Chronic Lymphocytic Leukemia
- D-Pharm Receives Top-line Results From Cardiac Safety Study with DP-b99
- D-Pharm Receives Top-line Results From Cardiac Safety Study With DP-b99
- Amarin's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization
- OptiNose Announces Publication of Positive Subgroup Analysis Evaluating Efficacy of Fluticasone Delivered with Novel Drug Delivery Technology
- Stelara Three-Year Efficacy and Safety Data Presented on Patients with Moderate to Severe Plaque Psoriasis
August 11, 2010
- PolyMedix Successfully Completes Phase 1B/2 Heparin Dose-Ranging Study with PMX-60056 Heptagonist
- Marinomed's Antiviral Effective in Clinical Trial for CommonCold - Study published in Respiratory Research
- Trigemina, Inc. Reports Positive Results with its Lead Compound TI-001 in a Phase IIa Clinical Trial for Chronic Daily Headache
- Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial
August 12, 2010
- Groundbreaking Study by AGH Neurosurgical Team Suggests Artery Compressing Base of Brain is Factor in Type 2 Diabetes Mellitus
- Novavax Reports Positive Results from Pre-Clinical Safety Study of Respiratory Syncytial Virus (RSV) Vaccine Candidate
August 13, 2010
- Lithium shows no benefit for people with ALS
- Elevated heart rate over time linked to significant risk of death
- "New" Human Adenovirus May Not Make for Good Vaccines, After All
August 16, 2010
- NanoViricides Reports that its Drug Candidates Demonstrated Significant Inhibition of Herpes Virus Infection
- Data on Investigational Drug Belatacept in Kidney Transplant Recipients to Be Presented at 23rd International Congress of The Transplantation Society
- In NIH-fuded Study, Researchers Uncover Early Step in the Cascade of Brain Events Leading up to Addiction
August 17, 2010
- Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
- Cardio3 BioSciences Publishes the Science Basis for C-Cure in JACC
- KineMed's Study of Merck's Ezetimibe (ZETIA) Invited to Join Best of AHA Specialty Conference Poster Session
August 18, 2010
- Uniform, National Measures Should Define HIV/AIDS Care
- Chronic Health Conditions Common for Stem Cell Transplant Survivors
August 20, 2010
August 23, 2010
- VA Research Finds Possible Link Between Head Trauma and Chronic Traumatic Encephalomyopathy
- BIND Biosciences Presents Preclinical Data for Novel Nanomedicine, BIND-014, at American Chemical Society National Meeting
- Two-Year Data from Phase 2 Trial of Genzyme's Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal Blood
- Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
- Celera Publishes Review Article on the KIF6 Gene Variant as a Predictor of Risk of Coronary Heart Disease (CHD) and Reduction in Coronary Events from Statin Therapy
August 24, 2010
- Ensemble Therapeutics Presents Data at American Chemical Society National Meeting
- Alnylam Scientists Present New Data on RNAi Therapeutics at American Chemical Society (ACS) 2010 National Meeting
- Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)
- Eisai Announces Positive Phase III Trial Results for Perampanel in Epilepsy
August 25, 2010
- Immuron Announces Results from Clinical Trial in Patients with NASH
- People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
- New ADHD Study Shows the Potential Efficacy of New Multi-Modal Hemispheric Based Program in Boosting Academic and Cognitive Performance of Children Who Exhibit Symptoms of Neurobehavioral Disorders Such as Attention Deficit Disorder (ADD), and Attention Deficit/Hyperactivity Disorder (ADHD)
- Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
- Old Drug Holds Promise Against Opportunistic Lung Bug
- Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
- Data on VIVUS' Qnexa to Be Presented at the European Society of Cardiology Congress
- Afferent Pharmaceuticals Announces Data Supporting Potential Utility of Proprietary P2X3 Antagonists in Regulating Bladder Reflexes
- FSH Society Applauds Study Pinpointing Genetic Causes of FSHD, Most Common Muscular Dystrophy
- Migraine sufferers have higher risk of dying from heart disease and stroke
August 26, 2010
- Karo Bio Presents Phase III Clinical Trials Design For Eprotirome
- Plexxikon Publishes PLX4032 Phase 1 Data Demonstrating 81 Percent Response Rate in Metastatic Melanoma Patients in the New England Journal of Medicine
- Cerulean Pharma Inc. Presents Data on Nanopharmaceutical Development Candidates and Platform Technologies at American Chemical Society National Meeting & Exposition
- Tranzyme Pharma to Present Ulimorelin Data Showing Reduction in Daily Vomiting in Patients with Diabetic Gastroparesis
- FibroGen Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration
August 27, 2010
- Mumps Vaccine Coverage Should Be Improved, Study Finds
- Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program
- Scientists find link in humans between nerve cell production, memory
- Vaccine has cut child cases of bacterial pneumonia, says study
- Acorda Therapeutics Announces Data on Ampyra (dalfampridine) Presented at American Academy of Neurology Meeting
- Frog skin may provide 'kiss of death' for antibiotic-resistant germs
- Researchers closer to development of drug to prevent deadly immune response
- Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
- First Isolation of Full-Length BRCA2 Protein Enabled by Bio-Rad Mini-PROTEAN TGX Precast Gels
August 30, 2010
- Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression
- BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010
- Pluristem's Placenta Derived Cells Chosen by European Commission's Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients
- Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients
- Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY(R) Trial Centers
- ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed with Urgent Angioplasty
- Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
- Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
August 31, 2010
- The RSV M37 Clinical Challenge Virus Manufactured by Meridian Life Science is a Powerful Tool for the Development of New RSV Vaccines and Therapeutics
- Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
- Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch
- Bionomics Presents BNC210 Data at Leading European Forum
- Cordis Announces Results of Ten-Year Cypher Sirolimus-Eluting Coronary Stent Follow-Up
- Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
- Pre and Post-Operative Use of Caldolor (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
- QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting
- Progenics Pharmaceuticals to Present Preclinical Study of Novel Monoclonal Antibodies Against C. difficile at 2010 ICAAC
- Success Stops Drug Trial
- Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients
- Increasing selenium intake may decrease bladder cancer risk
- Researchers to activate anti-cancer gene
- Cordis announces results of ten-year Cypher Sirolimus-eluting coronary stent follow-up
- New Data Supports Valdoxan?s Unique Clinical Signature
